Newly listed nerve-repair company ReNerve has inked an exclusive distribution partnership with Accession Medical Supplies for the sales and marketing ... Read More The post ReNerve inks deal to expand ...

YTD EBITDA increased to $7.5 million; a twenty-fold improvement compared to 2023-YTD EBITDA of $0.4 million2024-YTD Adjusted EBITDA increased 260% to $9.6 million compared to 2023-YTD of $3.7 millionF ...

Product sales for the three months ended September 30, 2024 was $597,677 compared to $3,631 in the three months ended ...

Orthocell (ASX:OCC) has appointed Device Technologies Asia as the exclusive distributor of its nerve repair device, Remplir, ...

FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025 Conference call to be held today at 10:00 am Eastern Time CAESAREA ...